PCI BIOTECH HOLDING ASA: årsregnskap 2010 vs 2009
Grew 21% on revenue
approved 2010-04-13; registry 2011-05-16; journal 2011 366262
Summary
What changed
Comparing Årsregnskap 2010 with 2009 for PCI BIOTECH HOLDING ASA. Revenue 8.61m NOK → 10.44m NOK (+21.3%). Net result -15.02m NOK → -13.94m NOK. Equity 59.43m NOK → 187.31m NOK.
On the constructive side: revenue rose; operating result improved; net result improved.
Also worth watching: paid-in equity reduced; payroll increased; book investments changed. All figures are taken from the published annual accounts for PCI BIOTECH HOLDING ASA.
At a glance
Scorecard
What improved
-
↑
Revenue rose
Operating income / revenue moved from 8.61m NOK to 10.44m NOK (+21.3% YoY). Calculated
-
↑
Operating result improved
Operating result -17.69m NOK → -16.24m NOK (op. margin -205.4% → -155.5%). Calculated
-
↑
Net result improved
Net result -15.02m NOK → -13.94m NOK (net margin -174.3% → -133.5%). Calculated
-
↑
Equity strengthened
Book equity 59.43m NOK → 187.31m NOK (equity ratio 97.0% → 99.6%). Calculated
-
↑
Cash rose
Bank deposits 6.48m NOK → 7.54m NOK (+16.4% YoY). Calculated
Things to notice
-
·
Paid-in equity reduced
Paid-in equity fell 16.11m NOK → 189.5k NOK — check capital reduction, conversion, or reclassification. Interpretation
-
·
Payroll increased
Salary cost 2.40m NOK → 4.91m NOK (28% → 47% of revenue). Calculated
-
·
Book investments changed
Investment / intangible book value 41.00m NOK → 85.00m NOK. Reported fact